Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
This article was originally published in The Tan Sheet
Executive Summary
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
You may also be interested in...
Perrigo’s New Papa: CEO Brings Product Development Know-How To Post
Joseph Papa brings 30 years of experience in healthcare and specialty generic pharmaceutical industries to his new position as president and CEO of Perrigo, the private-label manufacturer announced Sept. 11
Perrigo’s New Papa: CEO Brings Product Development Know-How To Post
Joseph Papa brings 30 years of experience in healthcare and specialty generic pharmaceutical industries to his new position as president and CEO of Perrigo, the private-label manufacturer announced Sept. 11
Perrigo’s New Papa: CEO Brings Product Development Know-How To Post
Joseph Papa brings 30 years of experience in healthcare and specialty generic pharmaceutical industries to his new position as president and CEO of Perrigo, the private-label manufacturer announced Sept. 11